Logo

American Heart Association

  46
  0


Final ID: MP2043

Effect of Subcutaneous (SC) Injection of Furosemide Compared with Intravenous (IV) Injection on Vital Signs in Healthy Volunteers

Abstract Body (Do not enter title and authors here): Introduction. Furosemide (FUR) remains the cornerstone agent to decongest patients with heart failure. Given the challenges associated with intravenous (IV) administration, an 80mg/10mL buffered formulation has been developed (Furoscix) to be administered subcutaneously (SC) over a period of 5 hours. This has demonstrated similar bioavailability and clinical efficacy to FUR IV with minimal impact on blood pressure (BP) and heart rate (HR). SCP-111 (FUR SC) is a novel SC injection FUR formulation in development with a concentration of 80mg/mL, and demonstrated similar bioavailability, diuretic, and natriuretic effects to FUR IV. However, its potential effects on BP and HR remain unknown.

Methods. Randomized, open-label, single-center, crossover study. Healthy volunteers were randomized 1:1 to either receive 80mg FUR IV given as two 40mg boluses separated by two 2 hours first or FUR SC 80 mg/mL as SC injection over 10 seconds. Systolic BP (SBP), diastolic BP (DBP), and HR were monitored at set time points for 12 hours and changes from baseline were calculated. Following a 3-day washout period, individuals received the opposite treatment, and the same evaluation was completed.

Results. The mean±SD baseline SBP and DBP for the FUR SC and FUR IV groups were 123±13 / 78±8 vs. 124±17 / 78± 9mmHg. Baseline HR were 69±9 and 69±10bpm, respectively indicating no difference between the groups. Mean change in SBP over the 12-hour follow-up ranged from -1.8 to -10.3mmHg for FUR SC and 1.5 to -11.3mmHg for FUR IV. The mean change in DBP ranged from 1.8 to -4.0mmHg for FUR SC and 5.5 to -3.7mmHg for FUR IV. The mean change in heart rate over the follow-up period ranged from 2.2 to -5.3bpm for FUR SC and 7.5 to -2.3bpm for FUR IV (Figure 1).

Conclusion. There were no clinically meaningful changes in blood pressure and heart rate over the 12-hour monitoring period in response to either FUR SC or FUR IV. Furosemide 80mg/mL administered as a SC injection was safe with regards to its effects on BP and HR and may become a potential alternative to IV furosemide in the near future.
  • Alexy, Tamas  ( University of Minnesota , Minnesota , Minnesota , United States )
  • Kamineni, Phani  ( scPharmaceuticals , Burlington , Massachusetts , United States )
  • Cornelius, Barbara  ( scPharmaceuticals , Burlington , Massachusetts , United States )
  • Tan, Sara  ( scPharmaceuticals , Burlington , Massachusetts , United States )
  • Mohr, John  ( scPharmaceuticals , Burlington , Massachusetts , United States )
  • Author Disclosures:
    Tamas Alexy: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Speaker:Edwards Life Sciences:Active (exists now) ; Consultant:Edwards Life Sciences:Active (exists now) ; Speaker:scPharmaceuticals:Active (exists now) ; Consultant:scPharmaceuticals:Active (exists now) ; Speaker:CVRx:Active (exists now) ; Speaker:Abbott:Active (exists now) ; Advisor:Abbott:Active (exists now) | Phani Kamineni: DO have relevant financial relationships ; Employee:SC Pharmaceuticals:Active (exists now) ; Individual Stocks/Stock Options:SC Pharmaceuticals:Active (exists now) | Barbara Cornelius: No Answer | Sara Tan: DO have relevant financial relationships ; Employee:scPharmaceuticals:Active (exists now) ; Individual Stocks/Stock Options:scPharmaceuticals:Active (exists now) | John Mohr: DO have relevant financial relationships ; Employee:scPharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Pharmacologic Management of Heart Failure and Cardiomyopathy

Monday, 11/10/2025 , 10:45AM - 12:00PM

Moderated Digital Poster Session

More abstracts on this topic:
Effectiveness of a Mobile Integrated Health vs Transitions of Care Coordinator in Heart Failure: Results from the MIGHTy-Heart Trial

Masterson Creber Ruth, Shafran Topaz Leah, Ellison Melani, Choi Jacky, Zhao Yihong, Turchioe Meghan, Daniels Brock

A Stroke Case Management Program To Improve Hospital Readmission Rates After Index Stroke

Kim Kyutae, Jaberizadeh Amir, Tucker Lue-yen, Malekyan Cristin, Mena Sarah, Shirazi Aida, Lynch Meaghan

More abstracts from these authors:
Pharmacokinetics and pharmacodynamics of SC furosemide in patients with HF and obesity

Alexy Tamas, Kamineni Phani, Harata Mikako, Luepke Katie, Goodwin Matthew, Mohr John

Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of furosemide (FUR)

Alcorn Harry, Mohr John, Cornelius Barbara, Luepke Katie, Kamineni Phani

You have to be authorized to contact abstract author. Please, Login
Not Available